Stockreport

enGene Reports Third Quarter 2025 Financial Results and Provides Business Update

enGene Holdings Inc.  (ENGN) 
PDF Achieved target enrollment milestone for LEGEND trial pivotal cohort in high-risk BCG unresponsive NMIBC with carcinoma in situLEGEND’s pivotal cohort data update planne [Read more]